Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.18 USD | +1.87% | +7.43% | +11.97% |
05-15 | Transcript : Aytu BioPharma, Inc., Q3 2024 Earnings Call, May 15, 2024 | |
05-15 | Earnings Flash (AYTU) AYTU BIOPHARMA Reports Q3 Revenue $18M, vs. Street Est of $17.4M | MT |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+11.97% | 17.71M | |
+38.69% | 728B | |
+33.91% | 603B | |
-4.49% | 360B | |
+20.24% | 332B | |
+2.12% | 279B | |
+16.23% | 244B | |
+7.71% | 207B | |
-5.48% | 205B | |
-0.35% | 163B |
- Stock Market
- Equities
- AYTU Stock
- News Aytu BioPharma, Inc.
- Transcript : Aytu Biopharma, Inc., Q1 2022 Earnings Call, Nov 15, 2021